drugset / Trial / NCT02033200

Safety Study Looking at the Effects of Stendra on Vision

NCT02033200

Phase 4 Completed 80 enrolled VIVUS LLC
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to see if Stendra causes any changes in vision, eye pressure, pupil dilation, and color vision in healthy males.

Timeline

Start
2014-01
Primary completion
2014-01
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Avanafil Small molecule 200 mg

Indications

No indication recorded.